The Court entered Case Management Order No. 34C regarding Wave 1 Remand Case Status.

The Court held oral argument on Defendant Sandoz, Inc.’s Motion for Relief from a Judgment, Order, or Proceeding. 

The Court entered an Order setting deadlines for the March 14, 2023, hearing on product identification deficiencies. 

The Court entered an Order setting deadline for partial dismissals and amended complaints for certain plaintiffs. 

The Court entered an Order dismissing certain cases who did not intend to appear at the next show cause hearing. 

The Court entered an Order dismissing certain cases subject to the next show cause hearing based upon stipulations filed by counsel. 

The Court scheduled the next Lead and Liaison and General Status Conferences for March 30, 2023, at 9:30 a.m. and 10:30 a.m., respectively.

The Court reset the February 7, 2023, show cause hearing to March 14, 2023, at 10:00 a.m.

The Court scheduled oral argument on Defendant Sandoz Inc.’s Motion for Relief from a Judgment, Order, or Proceeding for February 14, 2023, at 9:30 a.m.

The Court held a status conference with Lead and Liaison Counsel.

The Court granted a Motion for Reinstatement of Cases to Obtain Evidence Set Forth in Addendum to Case Management Order No. 12A. 

The Court ruled on a Motion for Reconsideration filed by certain Plaintiffs whose cases were dismissed by this Court’s Orders of July 13, 2022 (Doc. 14431) and July 18, 2022 (Doc. 14432).

The Court ruled on Plaintiff’s Motion to Vacate Voluntary Dismissal with Respect to Pfizer Inc. and Amended Motion to Vacate Voluntary Dismissal with Respect to Hospira, Inc. 

The Court ruled on Defendant Sanofi’s Motion for Judgment on the Pleadings.

The Court ruled on Plaintiff’s Motion for Reconsideration.

The Court ruled on Plaintiff’s Motion to Vacate and Reinstate. 

The Court issued an order setting deadlines for the February 7, 2023 show cause hearing.

The Court issued an Addendum to Case Management Order No. 12A. 

The Court reset the show cause hearing to February 7, 2023 at 10:00 a.m.

The Court issued an Addendum to Case Management Order No. 12A. 

The Court entered Case Management Order No. 37 regarding physician witness fees in wave case depositions.  

The Court issued an Amended Order denying Defendant Accord’s Motion for Summary Judgment on Preemption Grounds (Doc. 13425), Defendant Sandoz’s Motion for Summary Judgment on Preemption Grounds (Doc. 13445), and Defendant Hospira’s Motion for Summary Judgment on Preemption Grounds (Doc. 13857), and certifying the Court’s August 2, 2022, Order and Reasons (Doc. 14477) for interlocutory appeal. 

The Court issued an order setting a status conference with the settlement committee for January 25, 2023 at 10:00 a.m.

The Court held a status conference to discuss matters related to its August 2, 2022 Order and Reasons (Doc. 14477) and November 14, 2022 Order and Reasons (Doc. 15136). 

The Court ruled on Plaintiffs’ Motion to Modify Pretrial Order No. 19.

The Court ruled on Defendants’ Joint Motion to Certify Order for Interlocutory Appeal. 

The Court held a telephone status conference to discuss matters related to general expert preservation depositions.

The Court ruled on Plaintiff’s Motion for Relief from Judgment.

The Court held oral argument on Plaintiffs’ Steering Committee’s Motion to Modify Pretrial Order No. 19. 

The Court held a lead and liaison counsel conference, set the next show cause hearing for December 14, 2022, and set the next lead and liaison counsel conference for January 25, 2023 at 9:00 a.m. 

The Court issued Pretrial Order No. 127. 

The Court held oral argument on Defendants Sandoz, Hospira, and Accord’s Joint Motion to Certify Order for Interlocutory Appeal.

The Court issued an order providing that Judge Jane Triche Milazzo will preside over the general expert preservation deposition of David Madigan, PhD on November 14, 2022 and November 15, 2022 at 9:00 a.m., and that Magistrate Judge Michael North will preside over the general expert preservation deposition of Ellen Feigal, M.D. on January 26, 2023 and January 27, 2023 at 9:00 a.m.

The Court entered Case Management Order No. 36. 

The Court issued an order setting oral argument as to Plaintiffs’ Steering Committee’s Motion to Modify Pretrial Order No. 19 for November 4, 2022.

The Court held a status conference with liaison counsel to discuss matters related to the continuation of the September 13, 2022, show cause hearing.

The Court issued an order dismissing cases due to their inability to determine Product ID Information pursuant to CMO 12A. 

The Court held a telephone status conference with liaison counsel. 

The Court issued an order canceling the continuation of the show cause hearing set for September 15, 2022, to be reset at a later date.

The Court held a meeting with lead and liaison counsel and a general status conference. 

The Court held a show cause hearing. 

The Court issued an order granting Defendants’ joint motion for extension of deadlines and setting Defendants’ Joint Motion to Certify Order for Interlocutory Appeal (Doc. 14517) for oral argument at 10:00 a.m. on October 28, 2022. 

The Court issued an update on the status of the cases selected for Wave 1 discovery and remand.

Magistrate Judge Michael B. North held a telephone status conference to discuss matters related to the planned settlement conferences in 10 bellwether cases. 

The Court held a telephone status conference with liaison counsel. 

The Court ruled on Defendant Accord Healthcare Inc.’s Motion for Summary Judgment on Preemption Grounds. 

The Court issued an order setting deadlines for the September 13, 2022 Hearing on CMO 12A Product Identification Deficiencies. 

The Court issued CMO No. 35 setting the deadline for all Plaintiffs to effect service of process on all Defendants named in Plaintiffs respective Short Form Complaints.

The Court issued an order setting an oral hearing on Plaintiff’s Motion for Relief from Judgment 

The Court denied certain Motions for Summary Judgment without prejudice (Docs. 13580, 13581, 13582, 13583, 13584, and 13585). 

The Court denied three motions filed by Defendant Accord Healthcare, Inc. (Docs. 13781, 13782, and 13802).  

The Court held a General Status Conference and the parties discussed Joint Report No. 25. 

The Court issued PTO No. 126 setting the next CMO 12A & PTO 22A show cause hearing for September 13, 2022, and the next general status conference for September 14, 2022.

The Court held a Status Conference with Lead and Liaison Counsel.

The Court held a Status Conference with the Settlement Committee to discuss potential options related to bellwether settlement conferences. 

The Court issued an order denying certain motions as moot (Docs. 13771 and 13800).

The Court issued an order denying certain motions as moot (Docs. 14009 and 14202). 

The Court dismissed certain cases due to their inability to determine Product ID information.

Upon review of letter briefing submitted to the Court regarding CMO 12A deficiencies, the Court dismissed some matters and reset other matters for show cause. 

The Court held a Show Cause Hearing.

The Court dismissed certain cases due to their inability to determine Product ID information.

The Court held a Show Cause Hearing.

The Court issued an order setting a status conference with the Settlement Committee for July 21, 2022. 

The Court issued an order granting a motion for extension of deadlines and continuing the submission date on Plaintiff Elizabeth Kahn’s Motion for Relief from Judgment Pursuant to Rule 60(b) to July 6, 2022.

The Court issued an order setting deadlines for the parties to submit letter briefing on innovator liability.

The Court, having been advised by Magistrate Judge Michael B. North, that all parties have firmly agreed upon a compromise in the Barbara Earnest matter, issued an order dismissing the case without prejudice.

Magistrate Judge Michael B. North held a settlement conference with the parties involved in Plaintiff Barbara Earnest’s matter. 

The Court issued an update on the status of the cases selected for Wave 1 discovery and remand.

The Court held oral argument on Sanofi Defendants’ Motion for Summary Judgment and held an eligibility hearing for Wave 1 Remand. 

The Court held a status conference with liaison counsel.

The Court amended a previous order to clarify that the show cause hearing to address Product ID deficiencies is set for July 12, 2022. at 10:00 a.m. 

The Court adopted the Trial 1A deadlines proposed by the parties.

The Court set the eligibility hearing on cases selected for Wave 1 discovery and remand for June 3, 2022, at 10:00 a.m.

The Court set the next show cause hearing for July 12, 2022 at 10:00 a.m. The Court also set the next Lead and Liaison meeting at 9:00 a.m. on July 22, 2022, and the next general status conference at 10:30 a.m. on July 22, 2022. 

The Court set the show cause hearing to address the cases listed on Exhibit A for July 13, 2022, at 9:00 a.m. 

The Court held a show cause hearing. 

The Court held a status conference with lead and liaison counsel.

The Court held a show cause hearing that was partially continued from the show cause hearing held on April 28, 2022. 

The Court dismissed certain cases due to their inability to determine Product ID information. 

The Court held a show cause hearing. 

The Court identified the cases selected for Wave 1 discovery and remand in accordance with CMO 33. 

The Court held oral argument on Hospira’s Motion for Summary Judgment Based on Preemption. 

The Court set reset the time for the show cause hearing to be held on May 3, 2022 to 11:00 a.m.

The Court held a status conference to discuss the scheduling of Trial 1A. 

The Court set the next show cause hearing for May 3, 2022, at 1:00 p.m. The Court also set the next general status conference for May 3, 2022, at 10:30 a.m., to be preceded by a meeting with lead and liaison counsel at 9:00 a.m. 

The Court held a status conference to discuss the scheduling of Trial 1A. 

The Court established procedures for the selection, discovery, and remand for Wave 1. 

The Court held a status conference with liaison counsel. 

The Fifth Circuit reversed the judgment of this Court in Plaintiff Barbara Earnest’s case and remanded the cause for further proceedings. 

The Court held a show cause hearing. 

The Court held a general status conference and discussed the items set forth in Joint Report No. 23.

The Court held oral argument on the PSC’s Motion to Preserve Expert Testimony. 

The Court held a status conference with lead and liaison counsel. 

The Court issued an amended order regarding streamlined service on Accord Healthcare, Inc.

The Court held a status conference with liaison counsel. 

The Court ruled on Hospira’s Motion for Summary Judgment Based on the Statute of Limitations. 

The Court held oral arguments on two motions. 

The Court set oral argument for February 17, 2022. 

The Court set a status conference, oral argument, and a show cause hearing for March 8, 2022

The Court canceled the oral arguments set for January 25, 2022, to be reset at a later date. 

The Court ruled on Hospira’s Motion for Summary Judgment Based on the Statute of Limitations and canceled oral argument that was set for January 21, 2022. 

The Court held oral arguments on several motions.

The Court set oral argument on several motions for January 20th, 21st, and 25th.   

The Court ruled on Defendant Hospira’s Motion for Summary Judgment Based on Claims Under Illinois Law. 

The Court issued written reasons on Defendant Hospira’s Motion for Summary Judgment Based on the Learned Intermediary Doctrine. 

The Court held a show cause hearing.

The Court ordered that a show cause hearing will be held on December 22, 2021, at 10:00 a.m.

The Court ordered certain plaintiffs to show cause regarding CMO 12A product identification. 

The Court held a show cause hearing.

The Court ordered that a status conference with liaison counsel will be held on January 5, 2022, at 1:30 p.m.

The Court reset the show cause hearing to be held on December 15, 2021, from 10:30 a.m. to 8:30 a.m. 

The Court adopted the amended Trial 5 schedule proposed by the parties. 

The Court ruled on Hospira’s Motion for Summary Judgment Based on the Learned Intermediary Doctrine. 

The Court ordered that judgment be entered in favor of defendants Sanofi-Aventis U.S. LLC & Sanofi US Services Inc. and against plaintiff Elizabeth Kahn.  

Day eight of the second bellwether trial. Witness testimony and evidence entered and proffered. Both sides presented closing arguments. Jury charged. Verdict read in open court by the clerk and filed in the record.  

Day seven of the second bellwether trial. Witness testimony and evidence entered. Proffers made by counsel, and Plaintiff rested. 

Day six of the second bellwether trial. Witness testimony and evidence entered. 

Day five of the second bellwether trial. Witness testimony and evidence entered. 

The Court held a status conference to discuss matters related to deposition designations. 

Day four of the second bellwether trial. Witness testimony and evidence entered. 

Day three of the second bellwether trial. Witness testimony and evidence entered. 

The Court reset the show cause hearing that was set for November 23, 2021 to December 15, 2021. 

Day two of the second bellwether trial. Witness testimony and evidence entered. 

The second bellwether trial began. A jury of 8 was selected, sworn, and instructed. Both sides presented opening statements, and witness testimony and evidence was entered. 

The Court held a status conference to discuss matters related to the second bellwether trial set to begin on November 8, 2021.  
 

The Court held a telephone status conference to discuss matters related to the second bellwether trial set to begin on November 8, 2021.  
 

The Court held a status conference to discuss the responses to the jury questionnaires for the second bellwether trial and set another status conference for November 5, 2021. 
 

The Court held a status conference to discuss matters related to the deposition of a witness to be used during the second bellwether trial.       

The Court ordered certain trial preparation and procedures and adopted the parties’ proposed final pretrial order. 
 

The Court ordered that Audrey Plaisance be designated as the primary plaintiff for Trial 5. 
 

The Court set a status conference for November 2, 2021.
 

The Court issued a briefing schedule for the anticipated Motions for Summary Judgment based on preemption to be filed by certain Defendants. 
 

The Court issued a briefing schedule for the Plaintiffs whose claims Defendants seek to dismiss based on this Court’s Mixon ruling. 

The Court held a status conference. 
 

The Court held the final pretrial conference for the second bellwether trial. 
 

The Court held a status conference to discuss deposition designations.
 

The Court held a show cause hearing.
 

The Court held a conference with the parties to discuss deposition designations.
 

The Court set a conference to discuss deposition designations for October 12, 2021. 
 

The Court adopted the parties’ proposed amended deadlines for Trial 2A. 
 

The Court set a show cause hearing for November 23, 2021. 
 

The Court reset a show cause hearing for October 12, 2021. 
 

The Court set a show cause hearing for November 23, 2021. 

The Court ruled on several Motions in Limine. 
 

The Court held oral argument on several Motions in Limine. 
 

The Court adopted the parties’ proposed amended deadlines for Trial 5. 
 

The Court held a telephone status conference, set oral argument, and continued an in-person conference and the final pretrial conference.
 

The Court continued the second bellwether trial to November 8, 2021. 
 

The Court held a telephone status conference with liaison counsel to discuss the continuance of the trial set to begin on August 23, 2021.
 

The Court held a telephone status conference with liaison counsel to discuss matters related to the trial set to begin on August 23, 2021. 

The Court held oral argument on Defendant Sanofi’s Motion for Reconsideration. 
 

The Court held a status conference with liaison counsel. 

The Court held a telephone status conference with liaison counsel to discuss matters related to the trial set to begin on August 23, 2021. 

The Court ruled on Plaintiff’s Motion to Compel Sanofi to Produce Dr. Michael Kopreski at Trial for Live Cross Examination. 
 

The Court ruled on Defendant Sanofi’s Motion to Exclude Supplemental Opinion of Dr. Laura Plunkett. 
 

The Court set oral arguments, an in-person conference, and the final pretrial conference. 
 

The Court ruled on Defendant Sanofi’s Motion for Summary Judgment Based on Statute of Limitations. 
 

The Court ruled on Defendant Sanofi’s Motion to Exclude Expert Testimony of David B. Ross.
 

The Court ruled on Defendant Sanofi’s Motion for Reconsideration on Warnings Causation. 
 

The Court held a show cause hearing. 
 

The Court held a status conference with lead and liaison counsel. 
 

The Court ruled on Defendant Sanofi’s Motion for Reconsideration on Statute of Limitations. 

The Court adopted the parties’ proposed amended deadlines for Trial 2A.  

The Court appointed counsel to the 505(b)(2) Settlement Committee. 

The Court set a meeting, oral argument, and a show cause hearing for July 9, 2021.
 

The Court held oral argument on Hospira’s motions for Summary Judgment.
 

The Court held a general status conference and discussed the items set forth in Joint Report No. 22.
 

The Court held a status conference with lead and liaison counsel. 
 

The Court held oral argument on Defendant Sanofi’s Motions for Reconsideration. 
 

The Court held a show cause hearing.
 

The Court ruled on Sanofi’s Motion for Summary Judgment Based on Statute of Limitations relating to Plaintiff Melissa Roach. 
 

The Court ruled on Defendant Accord’s Motion for Summary Judgment on Prescription Grounds.
 

The Court ruled on Defendant Sandoz’s Motion for Summary Judgment.
 

The Court ruled on Defendant Sanofi’s Motion for Summary Judgment on Warnings Causation.
 

The Court clarified Case Management Order 32.
 

The Court continued the second bellwether trial to August 23, 2021.
 

The Court set a meeting, a status conference, and a show cause hearing for May 26, 2021, as well as a hearing with only the Finson Law Firm for May 25, 2021.
 

The Court held a show cause hearing. 
 

The Court held oral argument on Defendant Sanofi’s Motion for Summary Judgment on Warnings Causation and Motion for Summary Judgment Under the Doctrine of Judicial Estoppel.
 

The Court held a status conference with lead and liaison counsel, as well as trial counsel for the second bellwether trial.
 

The Court held a telephone status conference with counsel.
 

The Court ruled on a Motion for Summary Judgment on the Claims of Brenda Mixon and Entry of Order to Show Cause.
 

The Court ruled on Plaintiff’s Motion to Exclude Testimony of Dr. Azael Freites-Martinez. 
 

The Court ruled on Plaintiff’s Motion to Reconsider Order Regarding Dr. Madigan’s Meta-Analysis of Observational Studies. 
 

The Court ruled on Plaintiff’s Motion to Exclude Dr. Shapiro’s Opinions.
 

The Court ruled on Defendants’ Motion to Exclude Testimony of Dr. Antonella Tosti and Defendants’ Motion for Summary Judgment on Specific Causation.
 

The Court set a trial team meeting, a lead and liaison meeting, and a show cause hearing for April 14, 2021.
 

The Court held oral argument on several motions.
 

The Court held oral argument on several motions.
        

The Court held a telephone status conference with counsel and discussed the upcoming oral arguments.
 

The Court adopted the parties’ proposed amended deadlines for Trials 2A through 5, resetting Trial 2A for June 21, 2021.
 

The Court appointed a settlement master.
 

The Court held a show cause hearing. 
 

Judge Milazzo held a general status conference and discussed the items set forth in Joint Report No. 21.
 

The Court held a video status conference with lead and liaison counsel.
 

The Court held a video status conference to discuss the supplement expert report of Dr. Laura Plunkett. 
 

In accordance with Pretrial Order 105, the Court established a call docket procedure to govern amendments to complaints. 
 

The Court ruled on Plaintiff’s Motion to Exclude Testimony of Dr. Mamina Turegano. 
 

The Court ruled on Defendants’ Motion to Exclude Testimony of Linda Bosserman, M.D.
 

The Court ruled on Plaintiff’s Motion to Exclude Certain Opinions of Ellen T. Chang, Sc.D.
 

The Court ruled on Plaintiff’s Motion to Exclude Testimony of Professor L.J. Wei.
 

The Court ruled on Defendants’ Motion to Exclude Expert Testimony of Dr. David Madigan.
 

The Court appointed counsel to the 505(b)(2) Settlement Committee. 
 

The Court held a video status conference with counsel.
 

The Court set a meeting, a status conference, and a show cause hearing for February 19, 2021.
 

The Court ruled on Defendants’ Motion for Judgment on the Pleadings Based on the Statute of Limitations.
 

The Court held a telephone status conference with liaison counsel.
 

The Court set the fifth bellwether trial for January 24, 2022.
 

The Court held a telephone status conference with liaison counsel. 
 

The Court ruled on Plaintiffs’ Motion for Leave to File Amended Short Form Complaints of Bellwether Pool Plaintiffs.
 

The Court ruled on a Motion for Summary Judgment on the Claims of Sheila Crayton. 
 

The Court ruled on Defendants’ Motion to Exclude Expert Testimony of Dr. Laura Plunkett. 
 

The Court ruled on Defendants’ Motion to Exclude Expert Testimony of Dr. Ellen Feigal. 
 

The Court ruled on Plaintiff’s Motion to Exclude Causation Testimony of Dr. Gerald Miletello. 
 

The Court ruled on Plaintiff’s Motion to Exclude and/or Limit Testimony of Dr. Carl Kardinal and Dr. Zoe Larned. 
 

The Court selected certain Plaintiffs to proceed with discovery in preparation for the fifth bellwether trial.
 

The Court revised the dates for the remaining bellwether trials.
 

The Court ruled on Plaintiff’s Motion for Partial Summary Judgment on the Comparative Fault of her Treating Physicians and Misuse of Taxotere.
 

The Court ruled on Plaintiff’s Motion to Exclude Testimony of Dr. Janet Arrowsmith. 
 

The Court ruled on Plaintiff’s Motion to Exclude Testimony of John Glaspy, M.D.
 

The Court selected certain Plaintiffs to proceed with discovery in preparation for the fourth bellwether trial.
 

The Court continued the second bellwether trial.
 

The Court ruled on Plaintiff’s Motion for Partial Summary Judgment on Causation.
 

The Court ruled on Plaintiff’s Motion for Partial Summary Judgment on Affirmative Defenses Concerning Alternative Causes.
 

The Court ruled on a Motion for Reconsideration of Order Granting in Part Defendants’ Motion for Summary Judgment on the Claims of Plaintiffs Whose Taxotere Treatment Started Before December 15, 2006.
 

The Court ruled on a Motion for Summary Judgment Based on Preemption.
 

The Court held a show cause hearing.
 

The Court held oral argument on several motions.
 

The Court held a video status conference with lead and liaison counsel.
 

Judge North held a telephone status conference. 
 

The Court held oral argument on a Motion for Summary Judgment on the Claims of Plaintiff Brenda Mixon and a Motion for Judgment on the Pleadings Based on the Statute of Limitations Regarding the Claims of Plaintiff Juanita Greer.
 

The Court continued the events set for December 7, 2020 and reset them for December 14, 2020.
 

The Court issued an order regarding counsel holding positions in this MDL.
 

The Court amended certain pretrial deadlines for the third, fourth, and fifth bellwether trials.
 

The Court set a meeting, a show cause hearing, and oral argument for December 7, 2020.

The Court ruled on a Motion to Exclude Testimony of Michael Kopreski.
 

The Court held a show cause hearing.
 

The Court held a video status conference with lead and liaison counsel.
 

The Court held oral argument on several motions. 
 

The Court held oral argument on several motions. 
 

The Court ruled on Plaintiffs’ Motion for Leave to File Amended Short Form Complaints of Bellwether Pool Plaintiffs.
 

The Court set a meeting and show cause hearing for October 16, 2020.
 

The Court clarified its August 11, 2020 Order.
 

Per the parties’ agreement, the Court amended certain pretrial deadlines and trial dates.
 

The Court ruled on several Motions to Amend Complaints.
 

Judge Milazzo held a general status conference and discussed the items set forth in Joint Report No. 20.
 

The Court held a show cause hearing.
 

The Court held a video status conference with lead and liaison counsel.
 

The Court ruled on Plaintiffs’ Objections to Pretrial Order 105.
 

The Court ruled on a Motion for Summary Judgment Based on the Statute of Limitations relating to Plaintiff Antoinette Durden.
 

The Court ruled on a Motion for Summary Judgment Based on the Learned Intermediary Doctrine relating to Plaintiff Antoinette Durden.
 

The Court ruled on a Motion for Summary Judgment Based on the Statute of Limitations relating to Plaintiff Dora Sanford.
 

The Court ruled on Plaintiffs’ Motion for Partial Summary Judgment on Affirmative Defenses Under La. Rev. Stat. § 9:2800.59.

The Court continued the events set for July 15, 2020 and reset them for August 5, 2020.
 

The Court set a meeting, a general status conference, and a show cause hearing for July 15, 2020.

The Court ruled on Defendants’ Motion for Summary Judgment on the Claims of Plaintiffs Whose Taxotere Treatment Started Before December 15, 2006.

The Court ruled on a Motion to Amend Short Form Complaints of Bellwether Plaintiffs.

The Court granted Defendants’ Motion for Summary Judgment on the Claims of Plaintiffs whose Taxotere Treatment Started After December 11, 2015.

Per the parties’ agreement, the Court added four cases to the trial pool for the fifth bellwether trial.

The Court denied a Motion for Reconsideration relating to Plaintiff Elizabeth Kahn.

The Court issued an order on amendments to Short Form Complaints.

Per the parties’ agreement, the Court removed Plaintiff Sharon Allen from the trial pool.

The Court reset the second bellwether trial for October 19, 2020.

The Court set a show cause hearing for May 15, 2020, at 10:00 a.m.

The Court denied a Motion to Amend Pretrial Order 70B Regarding ex Parte Contact with MDL Plaintiffs’ Prescribing and Treating Physicians.

The Court granted a Motion for Summary Judgment against Plaintiff June Phillips.

The Court denied a Motion for Summary Judgment Based on Statute of Limitations against Plaintiff Elizabeth Kahn.

The Court ruled on a Motion for Summary Judgment Based on Causation against Plaintiff Elizabeth Kahn.

The Court dismissed certain cases.

The parties agreed to amend CMO 14E.

The Court granted a Motion for Summary against Plaintiff Kelly Gahan.

The Court selected certain Plaintiffs to proceed with discovery in preparation for the fourth bellwether trial.
 

The Court ruled on Plaintiffs’ Motion for New Trial.
 

Judge North held a discovery conference. 
 

Judge Milazzo held a status conference with counsel to discuss the selection of bellwether Plaintiffs.
 

Judge Milazzo held a status conference with the Settlement Committee. 
 

The Court set oral argument on several Motions for March 25, 2020, at 10:00 a.m.
 

The Court ruled on a Motion to Remand.
 

The Court held a status conference with liaison counsel. The Court set oral argument for March 11, 2020, at 10:00 a.m.
 

The Court set a status conference and show cause hearing for March 24, 2020, at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison and lead counsel at 9:00 a.m. The dial-in number for the general status conference and show cause hearing is 844-767-5679, and the access code is 1256321.

The Court continued the second bellwether trial.
 

Judge Milazzo ruled on Defendants’ Motion for Summary Judgment on the Claims of Plaintiff Cynthia Thibodeaux. 
 

The Court ruled on Plaintiffs’ Motion for Reconsideration or, in the Alternative, for Clarification/Amendment of Judgments. 
 

Judge North held a call docket conference. 
 

Judge Milazzo held a show cause hearing.

Judge Milazzo held oral argument on Defendants’ Motion for Summary Judgment on the Claims of Plaintiff Cynthia Thibodeaux. 
 

Judge Milazzo held a general status conference and discussed the items set forth in Joint Report No. 19.
 

Judge Milazzo held a status conference with liaison and lead counsel.
 

Judge Milazzo met with liaison counsel. The Court ordered that the parties should submit to the Court no later than January 17, 2020, the proposed final schedules for the upcoming bellwether trials. 
 

Judge Milazzo ruled on Plaintiffs’ Motion for Leave to File Amended Short-Form Complaints for Third Bellwether Trial Plaintiffs. 
 

Judge Milazzo ruled on Plaintiffs’ Motion for Leave to File Plaintiffs’ Third Amended Master Long-Form Complaint and Jury Demand.
 

The Court set a status conference and show cause hearing for January 9, 2020, at 9:30 a.m.

Judge Milazzo held oral argument on several motions. 
 

Judge North held a discovery conference regarding the depositions of Drs. Kessler, Madigan, and Plunkett.
 

Judge Milazzo met with Plaintiff Sheila Crayton and counsel.

Judge Milazzo held a show cause hearing.
 

Judge Milazzo held a general status conference and discussed the items set forth in Joint Report No. 18.
 

Judge Milazzo held a status conference with liaison and lead counsel.

Judge North held a discovery conference. 

The Court selected plaintiffs to proceed with discovery for the third bellwether trial.
 

Judge Milazzo set a status conference for November 7, 2019, at 10:45 a.m. in Judge Milazzo’s courtroom (C224). The call-in number for the conference is (800) 700-7784, and the access code is 473330. The conference will be preceded by a meeting with lead and liaison counsel at 9:45 a.m. 

A show cause hearing will follow at 1:00 p.m. on November 7, 2019. The call-in number for the show cause hearing is (800) 260-0719, and the access code is 473329.

Judge Milazzo held a status conference with the Settlement Committee. The Court set the next conference with the Settlement Committee for February 13, 2020 at 9:30 a.m.

Judge North held a discovery conference. 

Judge Milazzo presided over a jury trial in the matter of Barbara Earnest v. Sanofi. 

Judge Milazzo issued an order amending a previous Minute Entry.

Judge Milazzo ruled on several Motions in Limine. 

Judge Milazzo ruled on several Motions in Limine. 

Judge Milazzo held oral argument on several motions.

Judge Milazzo ruled on the Sanofi Defendants’ Motion to Exclude Expert Testimony of David A. Kessler. 

Judge Milazzo denied a Motion Pursuant to 28 U.S.C. § 1292(b) to Certify the Court’s July 9, 2019 Summary Judgment Order for Interlocutory Appeal and Adjourn the Earnest Trial Pending the Appeal.

Judge Milazzo held a pretrial status conference in the matter of Barbara Earnest v. Sanofi.
 

Judge Milazzo ruled on Plaintiff Barbara Earnest’s Motion to Exclude Dr. Shapiro’s and Dr. Smart’s Stem Cell Opinions. 

Judge Milazzo ruled on the Sanofi Defendants’ Motion to Exclude Expert Testimony of Dr. Laura Plunkett. 

Judge Milazzo ruled on a Motion to Exclude Expert Testimony on General Causation, a Motion to Exclude Expert Testimony of David Madigan, and a Motion to Exclude Expert Testimony of Ellen Feigal. 

Judge North ruled on the PSC’s Motion to Compel Compliance with Discovery Order Regarding 30(b)(6) Depositions.
 

Judge Milazzo held a status conference with liaison and lead counsel.

Judge Milazzo held oral argument on two motions.
 

Judge Milazzo held a status conference with the Settlement Committee. The Court set the next conference with the Settlement Committee for October 10, 2019.

Judge Milazzo held a show cause hearing. 

Judge Milazzo denied Plaintiff Barbara Earnest’s Motion to Exclude Expert Testimony that Relies Upon Defendants’ Employee Dr. Michael Kopreski. 

Judge Milazzo held oral argument on several motions. 

Judge Milazzo set a conference with lead and liaison counsel for August 16, 2019, at 9:00 a.m.

Judge Milazzo ruled on the Sanofi Defendants’ Motion to Exclude Expert Testimony of Dr. Linda Bosserman.

Judge Milazzo held a telephone status conference with counsel. 

The Court set a show cause hearing for August 15, 2019, at 2:00 p.m. in Judge Milazzo’s courtroom (C224). The dial-in number is (800) 260-0719 and the access code is 470482.
 

The Court made its initial selection of plaintiffs for the fourth and fifth bellwether trials. The parties must raise any objections by August 9, 2019.

Judge Milazzo heard oral argument on several motions. 

Judge Milazzo cancelled certain oral arguments and continued the oral argument on Defendants’ Motion for Summary Judgment on Preemption. 

Judge Milazzo held a status conference with liaison counsel. The Court set a status conference and show cause hearing for August 16, 2019. (The status conference has since been continued, and the show cause hearing has since been rescheduled for August 15, 2019.)
 

The Court continued the date by which the Court will select a pool of plaintiffs for the fourth and fifth bellwether trials. 

The Court established a procedure for the enforcement of subpoenas issued to non-parties located outside of the Eastern District. 

The Court amended the schedule for the second and third bellwether trials. 

The Court established a new procedure for the selection of trial plaintiffs for the fourth and fifth bellwether trials. 

Judge Milazzo set oral argument on several motions for July 25, 2019.

Judge Milazzo held a telephone status conference with liaison counsel. 

Judge North held a discovery/status conference regarding the discovery of documents relating to Shirley Ledlie. The Court also discussed issues relating to third-party subpoenas. 
 

Judge Milazzo held a show cause hearing.

Judge Milazzo held oral argument on six motions. 

The Court set a status conference for July 11, 2019, at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison and lead counsel at 9:00 a.m. The dial-in number for the general status conference is (800) 260-0702, and the access code is 468092.

A show cause hearing will follow beginning at 1:00 p.m. on July 11, 2019. The hearing will be held in Judge Milazzo’s courtroom. The dial-in number for the show cause hearing is (800) 260-0702, and the access code is 468091.
 

Judge Milazzo held a show cause hearing.

Judge Milazzo held a status conference with liaison and lead counsel. 

The Court amended CMO 14, CMO 14A, and CMO 14B to add provisions relating to trial pool plaintiffs.  

The Court amended CMO 14 and CMO 14A to revise the deadlines for the first bellwether trial.

Judge North held a telephone discovery status conference regarding whether Plaintiff Debra Cantwell should produce certain ESI.

The Court set a status conference and show cause hearing for May 21, 2019, at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison and lead counsel at 9:00 a.m. The dial-in number for the general status conference and show cause hearing is (800) 260-0712 and the access code is 466264.

Judge Milazzo held a show cause hearing.

Judge Milazzo held oral argument on Defendants’ Motion for Summary Judgment Against Plaintiff Deborah Johnson (Doc. 5734) and on Defendants’ Motion for Summary Judgment Against Plaintiff Jacqueline Mills (Doc. 5732).

Judge Milazzo held a general status conference and discussed the items set forth in Joint Report No. 16.

Judge Milazzo held a status conference with lead and liaison counsel.

Judge North ruled on an in camera submission of certain materials relating to work done by Dr. Curtis Thompson. 

Judge North held a call docket pursuant to Pretrial Order 85.

The Court held a status conference with liaison counsel. The parties updated the Court on the status of the case.

The Court ordered that the first bellwether trial previously set for Mary 13-24, 2019 is continued to September 16-27, 2019.

Judge Milazzo ordered that for any filing exceeding 50 pages in total length, counsel is required to deliver a hard copy of the filing and all exhibits to the Court.

Judge North held a hearing on a Motion to Quash or Modify Document Subpoena and for Protective Order.

The Court held a status conference with the Settlement Committee. The next conference with the Settlement Committee will be held on June 13, 2019.

The Court set a status conference and show cause hearing for April 4, 2019, at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison and lead counsel at 8:30 a.m. The dial-in number for the status conference and show cause hearing is (800) 260-0712 and the access code is 465448.

The Court held a status conference with liaison counsel. The parties updated the court on the status of the case. The Court set a status conference for April 4, 2019.

The Court held a status conference and discussed the items set forth in Joint Report No. 15. The Court then held a show cause hearing. 

The Court held a status conference with lead and liaison counsel. The Court set a conference with liaison counsel for March 12, 2019. There will be no general status conference following this conference.

Judge North held a discovery conference. 

The Court dismissed the cases of Plaintiffs who failed to address deficiencies as ordered at the show cause hearings on December 19, 2018, and January 18, 2019. 

Judge North held a hearing. 

The Court reappointed counsel to various positions. The appointments include: (1) Plaintiffs’ Liaison Counsel; (2) Plaintiffs’ Executive Committee; (3) Plaintiffs’ Steering Committee; and (4) Plaintiffs’ Federal-State Liaison Counsel.

The Court issued Case Management Order 16 designating the following Plaintiffs to proceed to the second phase of discovery for the second bellwether trial: (1) Cynthia Thibodeaux (Primary Plaintiff); and (2) Shelia Crayton.

The Court set a status conference and show cause hearing for February 21, 2019, at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison and lead counsel at 8:30 a.m. The dial-in number for the status conference and show cause hearing is (800) 260-0712 and the access code is 463704.

The Court held a show cause hearing.

The Court held a status conference and discussed the items set forth in Joint Report No. 14.

The Court heard oral argument on Plaintiff Antoinette Durden’s Motion to Enforce CMO 12A (Rec. Doc. 5518).

The Court held a status conference with liaison and lead counsel.

Magistrate Judge North held a discovery status conference. The next discovery status conference will take place February 20, 2019 at 1:00 p.m.

The Court issued an Order and Reasons on several Motions for Reconsideration seeking relief from the Court’s Order on Responses to Show Cause No. 2.

The Court issued an Order and Reasons on a Motion for Reconsideration relating to Plaintiff Patsy Hays.

The Court issued an Order and Reasons on a Motion for Reconsideration relating to Plaintiff Tukesha Burks.

The Court issued an Order and Reasons on a Motion for Reconsideration relating to Plaintiff Frances Dennis.

The Court dismissed several cases for failure to submit a Plaintiff Fact Sheet.

Magistrate Judge North set briefing deadlines on the issue of the PSC’s request for 30(b)(6) testimony from Sanofi. Judge North set a hearing on the matter for February 6, 2019, at 11:00 a.m.

The Court set a status conference and show cause hearing for January 18, 2019, at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison and lead counsel at 8:30 a.m. The dial-in number for the status conference and show cause hearing is (800) 260-0712 and the access code is 461324.

The Court issued an Order and Reasons denying Plaintiff Kelly Gahan’s Motion for Reconsideration of Court’s Order Granting in Part Sanofi’s Motion for Rule 37 Sanctions.

The Court held a show cause hearing.

The Court held a status conference with liaison and lead counsel.

Judge North held a status conference.

The Court dismissed the cases of Plaintiffs who failed to submit a Plaintiff Fact Sheet as ordered at the November 15, 2018 hearing.

The Court held a telephone status conference and ordered that the 505(b)(2) Defendants are permitted to have two representatives attend the depositions of Plaintiffs’ experts on general issues.

The Court reappointed Douglas J. Moore as Defense Liaison Counsel for Defendants sanofi-aventis U.S. LLC and Sanofi U.S. Services, Inc., and the Court reappointed certain individuals to the Settlement Committee for sanofi-aventis U.S. LLC and Sanofi U.S. Services, Inc.

The Court reappointed certain individuals to the Plaintiffs’ Settlement Committee.

The Court reappointed John F. Olinde as Defense Liaison Counsel for the 505(b)(2) Defendants, and the Court appointed certain individuals to the 505(b)(2) Settlement Committee.

Judge Milazzo issued an order governing the dismissal with prejudice by a non-Trial Pool Plaintiff as to the entire action against all defendants.

The Court set a show cause hearing for December 19, 2018, at 10:00 a.m. in Judge Milazzo's courtroom (C224). It will be preceded by a meeting with liaison and lead counsel at 9:00 a.m. The dial-in number for the show cause hearing is (800) 260-0702 and the access code is 457635.

Judge North held a discoverty status conference.

The Court held a general status conference and discussed those items set forth in Joint Report No. 13. The Court then held a show cause hearing.

The Court held a status conference with liaison counsel and lead counsel.

Judge North issued an order setting hte protocol for the determination of deficencies on issues related to non-bellwether Plaintiffs' obligations under Pre-Trial Order 71A and the Federal Rules of Civil Procedure.

Judge North issued an order replacing Pre-Trial ORder 10A. PTO 70B governs the parties' interactions with an MDL Plaintiff's prescribing and treating physicians in cases subject to Case Management Orders 14, 14A, and any trial Plaintiffs once identified in a similar trial scheduling CMO.

Judge Milazzo issued Case Management Order 15 regarding pathology protocol for the preservation and testing of tissue samples taken from Plaintiffs and the handling of Plaintiffs' pathology slides.

The Court issued Case Management Order 14A amending CMO 14.

Judge Milazzo issued an Order and Reasons granting in part Plaintiffs' Motion for Review of Discovery Order Authorizing Discovery from Consulting Experts Before any Witness Designation Is Due.

Judge Milazzo held a status conference with liaison counsel to discuss depositions.

Judge North held a status conference.

Judge Milazzo issued an order granting in part Defendant Accord Healthcare, Inc.'s Motion for Summary Judgement Based on Judicial Estoppel.

The Court set a status conference for November 15, 2018, at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison counsel and lead counsel at 8:30 a.m. To participate in the status conference, call (800) 260-0702 and enter access code 455209.

Judge Milazzo issued an Order and Reasons denying Plaintiff Kalyani Mokkapati’s Motion to Remand to the California Superior Courts.

The Court held a show cause hearing.

The Court held a general status conference. Discussed were those items set forth in Joint Report No. 12.

The Court held a status conference with liaison counsel and lead counsel.

Judge North issued an Order and Reasons, ordering Plaintiffs to produce certain documents including pathology reports pertaining to Plaintiffs’ scalp biopsies and records of psychiatric and/or physiological examinations of Plaintiffs.

This stipulated order establishes a streamlined service of process for Defendant Sagent Pharmaceuticals, Inc.

This stipulated order delineates the process for adding Sagent Pharmaceuticals, Inc., as a Defendant in this Multidistrict Litigation.

The Court set a status conference for September 27, 2018, at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison counsel, lead counsel, and members of the Plaintiffs’ Steering Committee at 8:30 a.m. To participate in the status conference, call (800) 700-7784 and enter access code 453654.

Judge North held a status conference.

The Court held a general status conference. Discussed were those items set forth in Joint Report No. 11.

The Court held a status conference with liaison counsel, lead counsel, and members of the Plaintiffs’ Steering Committee. 

Magistrate Judge North held a hearing on this date.

The Court modified Pre-Trial Order 22 regarding the procedure for show cause orders. PTO 22A governs the Defendants’ requests for dismissal of complaints that allegedly fail to submit a complete and verified Plaintiff Fact Sheet. 

The Court modified Case Management Order 12 to clarify the parties’ obligations and the procedures governing the discovery of Product ID Information and subsequent dismissal of defendants whose product was not used. CMO 12A supersedes CMO 12.

The Court set a status conference for August 16, 2018 at 10:00 a.m. in Judge Milazzo’s courtroom (C224). It will be preceded by a meeting with liaison and lead counsel at 8:30 a.m. To participate in the status conference, call (800) 260-0718 and enter access code 452537.

Magistrate Judge North heard argument on a Motion for Protective Order. Judge North’s rulings are reflected in the minute entry. The next discovery/status conference with Judge North will be held on August 7, 2018, at 1:00 p.m. 

Judge Milazzo heard argument on a Motion for Sanctions Pursuant to FRCP 37. The motion was taken under submission by the Court.

Judge Milazzo held a general status conference. Discussed were those items set forth in Joint Report No. 10.

Judge Milazzo held a status conference with liaison counsel, lead counsel, and members of the Plaintiffs’ Steering Committee.

Judge Milazzo held a status conference with liaison counsel and lead counsel. The parties updated the Court on the status of the case. 

Magistrate Judge North held a status conference on this date.

The Court issued Case Management Order 14 setting trial and pre-trial scheduling dates, and superseding Case Management Order Nos. 3, 4, 6, 8, 8A, 8B, 10, and 11.

The Court set the next general status conference for July 18, 2018 at 10:30a.m. in Judge Milazzo’s courtroom (B224). It shall be preceded by a meeting with liaison and lead counsel at 8:30 a.m. and a Steering Committee meeting at 9:30 a.m. To participate, call (800) 260-0719 and enter access code 450774.

The Court held a status conference with Liaison Counsel and Lead Counsel for Plaintiffs and Santofi.

The Court will hold a Science Day on June 27, 2018 for the parties to provide the Court with an overview of general medical and scientific issues in this litigation, presented in an objective direct examination lecture format without advocacy. The Parties have agreed to a set of ground rules. The Court session shall be "off the record," closed to the public and to any persons other than the Parties, admitted counsel for the Parties, the Parties' experts who will make the presentations, and court staff. There will be no court reporter or transcript taken. No electronic devices or writing materials will be allowed in the Courtroom.

The Panel has been notified of the need to reassign the above litigation to another judge in the Eastern District of Louisiana.

IT IS THEREFORE ORDERED that, with the consent of that court, this litigation is reassigned to the Honorable Jane Triche Milazzo for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407.

The Court issued an Order and Reasons, ruling on the issue of severance of multi-plaintiff cases in relation to Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Superior Courts of California (Rec. Doc. 469) and remanding two multi-plaintiff cases, Ernyes-Kofler, et al. v. Sanofi S.A. et al., Case No. 2:17-cv-03867, and McCallister, et al. v. Sanofi S.A. et al., Case No. 2:17-cv-02356, to the Superior Courts of California.

Magistrate Judge Michael B. North issued a Discovery Order, ruling on issues relevant to the “Taxotears” Google Group.

A status conference was held on this date with Magistrate Judge Michael B. North, and the Court made various rulings that are reflected in the minute entry.

The Court issued Case Management Order No. 8B, granting the Unopposed Motion of Sandoz Inc. to Substitute Trial Plaintiff in the Trial Scheduling Order for MDL Trial No. 2 (Rec. Doc. 2330) and amending Case Management Order No. 8A (Rec. Doc. 1099).

A status conference was held in Judge Engelhardt’s courtroom at 10:00 a.m. Discussed were those items set forth in Joint Report No. 9.

The Court issued Pretrial Order No. 44A, granting the 505(b)(2) Defendants' Motion to Replace Settlement Counsel for Accord Healthcare Inc. and Sandoz Inc. (Rec. Doc. 2266) and amending Pretrial Order No. 44 to replace certain members of the 505(b)(2) Settlement Committee.

A status conference was held on this date with Magistrate Judge Michael B. North, and the Court made several rulings that are reflected in the minute entry.

The Court issued an Order, ruling on the responses to this Court’s November 15, 2017 Order to Show Cause No. 2 (Rec. Doc. 1103).

The Court held a status conference with Plaintiffs Liaison Counsel, Dawn M. Barrios and M. Palmer Lambert, and Defendants’ Liaison Counsel, Douglas J. Moore and John F. Olinde.

The Court issued Pretrial Order No. 77A, replacing Pretrial Order No. 77 (Rec. Doc. 1633) regarding streamlined briefing for future cases removed to this MDL from California Superior Courts naming McKesson Corporation.

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Pretrial Order No. 78, setting the next meeting of liaison counsel and the Court for Monday, April 16, 2018, at 9:30 a.m. and setting the next general status conference for Thursday, April 26, 2018, at 10:00 a.m. in the undersigned’s courtroom, with the meeting of liaison counsel at 8:30 a.m. and meeting of the Plaintiffs’ Steering Committee at 9:00 a.m. The Court has set up a conference line for the status conference. To participate, call (800) 260-0719 and enter access code 447200.

A status conference was held on this date with Magistrate Judge Michael B. North, and certain deadlines contained in Case Management Order No. 3 (Rec. Doc. 669) were extended.

The Court issued Order to Show Cause No. 3, requiring Plaintiffs who are listed on the attached exhibits to show cause in writing on or before Monday, April 23, 2018, as to why their case should not be dismissed with prejudice for failure to comply with Amended Pretrial Order No. 22 (Rec. Doc. 325).

A status conference was held on this date with Magistrate Judge Michael B. North.

Magistrate Judge Michael B. North issued an Order and Reasons relevant to the parties’ dispute concerning ten (10) documents over which Sanofi claimed privilege.

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Case Management Order No. 13, selecting four plaintiffs to proceed to the second phase of discovery for the first bellwether trial.

A status conference was held in Judge Engelhardt’s courtroom at 10:00 a.m. Discussed were those items set forth in Joint Report No. 8.

The Court issued Order to Show Cause No. 3, requiring Plaintiffs who are listed on the attached exhibits to show cause in writing on or before Monday, March 5, 2018, as to why their case should not be dismissed with prejudice for failure to comply with Amended Pretrial Order No. 22 (Rec. Doc. 325).

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Pretrial Order No. 37A, amending and superseding Pretrial Order No. 37 (Rec. Doc. 318) and attaching the exemplar Short Form Complaint to be used by counsel when filing their complaints as provided by this Order and Pretrial Order No. 15 (Rec. Doc. 230). The PDF version of the exemplar Short Form Complaint is available under the “Forms” tab on this webpage.

A status conference was held on this date via telephone with Magistrate Judge Michael B. North.

The Court issued Pretrial Order No. 77, establishing a streamlined briefing procedure for future cases removed to this MDL from California Superior Courts naming McKesson Corporation.

The Court held a status conference with Plaintiffs Liaison Counsel, Dawn M. Barrios and M. Palmer Lambert, and Defendants’ Liaison Counsel, Douglas J. Moore and John F. Olinde.

The Court issued Pretrial Order No. 76, setting the next meeting of liaison counsel for Monday, February 5, 2018, at 9:30 a.m. and setting the next general status conference for Wednesday, March 7, 2018, at 10:00 a.m. in the undersigned’s courtroom, with the meeting of liaison counsel at 8:30 a.m. and meeting of the Plaintiffs’ Steering Committee at 9:00 a.m. The Court has set up a conference line for the status conference. To participate, call (800) 260-0702 and enter access code 444319.

The Court issued Pretrial Order No. 71A, amending and superseding Pretrial Order No. 71 (Rec. Doc. 1306) and governing Plaintiffs’ responsibilities relevant to electronically stored information (ESI) as required by the Plaintiff Fact Sheet.

The Court issued Pretrial Order No. 70A, amending and superseding Pretrial Order No. 70 (Rec. Doc. 1137) and governing the parties’ interactions with an MDL Plaintiff’s prescribing and treating physicians.

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued an Order, stating that if Plaintiffs have substantially complied with the obligations identified in Paragraph 1 of Case Management Order No. 12 (Rec. Doc. 1506) prior to the entry of Case Management Order No. 12, they shall notify Defendants in accordance with Paragraph 3 of Case Management Order No. 12 by Wednesday, January 31, 2018.

The Court issued Pretrial Order No. 75, reappointing counsel to various positions within MDL 2740 for a term beginning on the date of this Order until January 1, 2019. Applications for the subsequent term shall be submitted no later than November 15, 2018.

The Court issued Case Management Order No. 12, governing the procedures that Plaintiff’s counsel must follow with regard to product identification.

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Pretrial Order No. 74, governing the procedures for withdrawal of Plaintiff’s counsel.

The Court issued Pretrial Order No. 73, granting Defendants’ Motion for Substitution of Second Amended Exemplar Short Form Complaint (Rec. Doc. 1254) and ordering that the version of the Short Form Complaint attached as Exhibit A to this Order be substituted in place of the current Amended Exemplar Short Form Complaint that is found as Exhibit A (Rec. Doc. 318-1) to Pretrial Order No. 37 (Rec. Doc. 318). This form is available under the “Forms” tab of this webpage and through MDL Centrality.

The Court issued Pretrial Order No. 72, dismissing Defendants Sanofi S.A. and Aventis Pharma S.A. (“French Defendants”) without prejudice pursuant to a “Stipulation of Terms Related to Defendants, Sanofi and Aventis Pharma S.A.” (Rec. Doc. 1072) filed by the parties.

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Case Management Order No. 11, extending certain deadline established in Case Management Order No. 3 (Rec. Doc. 669).

A status conference was held in Judge Engelhardt’s courtroom at 10:00 a.m. Discussed were those items set forth in Joint Report No. 7.

The Court issued Pretrial Order No. 71, governing Plaintiffs’ responsibilities relevant to electronically stored information (ESI) as required by the Plaintiff Fact Sheet.

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued an Order, ruling on the responses to this Court’s November 2, 2017 Order to Show Cause (Rec. Doc. 1065).

The Court issued an Order of Severance, granting the Plaintiffs’ Steering Committee’s Ex Parte Motion for Order of Severance pursuant to Pretrial Order No. 65 (Rec. Doc. 1120) and severing the multi-plaintiff cases contained within the Order.

The Court issued Case Management Order No. 10, governing the initial phase of case-specific discovery for cases identified in Case Management Order No. 8A (“CMO No. 8A”) (Rec. Doc. 1099).

The Court issued an Order, scheduling a status conference with Magistrate Judge Michael B. North for December 14, 2017 at 10:00 a.m.

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued an Order and Reasons, granting Defendants’ Motion to Issue Written Discovery (Rec. Doc. 904).

The Court issued an Order and Reasons, denying without prejudice Defendants’ Motion for Case Substitution Protocol (Rec. Doc. 888).

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Pretrial Order No. 70, governing the parties’ interactions with an MDL Plaintiff’s prescribing and treating physicians.

The Court held a status conference with Plaintiffs Liaison Counsel, Dawn M. Barrios and M. Palmer Lambert, and Defendants’ Liaison Counsel, Douglas J. Moore and John F. Olinde.

The Court issued Case Management Order No. 9, establishing the protocol for depositions conducted of both fact and expert witnesses in cases presently pending and hereafter included in the MDL as described more fully within the Order.

The Court issued Order to Show Cause No. 2, requiring Plaintiffs who are listed on the attached exhibits to show cause in writing on or before Friday, December 15, 2017, as to why their case should not be dismissed with prejudice for failure to comply with Amended Pretrial Order No. 22 (Rec. Doc. 325).

The Court issued an Order, granting a Joint Motion to Withdraw Certain Motions and Response (Rec. Doc. 1074) as stipulated by the parties.

The Court issued an Order, granting a Joint Motion to Withdraw (Rec. Doc. 913) documents related to Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Twenty-Second Judicial Circuit, City of St. Louis, State of Missouri (Rec. Doc. 467).

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Case Management Order No. 8A, amending and superseding Case Management Order No. 8 (Rec. Doc. 935) and establishing the procedures and deadlines applicable to the second bellwether trial, which is set for Monday, January 28, 2019 at 8:30 a.m.

The Court issued Pretrial Order No. 69, reminding all counsel of the Wednesday, November 15, 2017 deadline to submit applications to the Court for the various appointed positions within the MDL for the upcoming term.

The Court issued Pretrial Order No. 68, setting various deadlines and providing guidance as to the type of photographs that should be submitted pursuant to the revised Plaintiff Fact Sheet (Rec. Doc. 236-1).

The Court issued an Order to Show Cause, requiring Plaintiffs who are listed on the attached exhibits to show cause in writing on or before Friday, November 3, 2017, as to why their case should not be dismissed with prejudice for failure to comply with Amended Pretrial Order No. 22 (Rec. Doc. 325).

A status conference was held in Judge Engelhardt’s courtroom at 10:00 a.m. Discussed were those items set forth in Joint Report No. 6 (Rec. Doc. 454).

The Court issued an Order and Reasons, denying without prejudice Defendants Sanofi-Aventis U.S. LLC and Sanofi US Services Inc.’s Motion to Dismiss Claims Barred by the Applicable Statute of Limitations (Rec. Doc. 494).

The Court issued Pretrial Order No. 67, scheduling the next meeting of liaison counsel with the Court for Friday, November 17, 2017 at 9:30 a.m. and scheduling the next general status conference for Friday, December 15, 2017 at 10:00 a.m. in Judge Engelhardt’s courtroom, with the meeting of liaison counsel at 8:30 a.m. and meeting of the Plaintiffs’ Steering Committee at 9:00 a.m. The Court has set up a conference line for the status conference. To participate, call (866) 615-1886 and enter access code 432133.  

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Pretrial Order No. 66, clarifying this Court’s ruling (Rec. Doc. 784) on Delaware Plaintiffs’ Motion to Remand to the Superior Court of Delaware (Rec. Doc. 473).

The Court issued an Order, rescheduling oral argument on Sanofi-Aventis U.S. LLC and Sanofi US Services, Inc.’s Motion to Compel Production of Electronically Stored Information (Rec. Doc. 918) for October 26, 2017 at 3:00 p.m. before Magistrate Judge Michael B. North.

The Court issued an Order, setting oral argument on Sanofi-Aventis U.S. LLC and Sanofi US Services, Inc.’s Motion to Compel Production of Electronically Stored Information (Rec. Doc. 918) for November 1, 2017 at 11:00 a.m. before Magistrate Judge Michael B. North.

The Court issued Pretrial Order No. 65, establishing the procedure for severance of multi-plaintiff cases.

Defendants filed Answers to Plaintiffs’ First Amended Master Long Form Complaint (Rec. Doc. 689).

The Court issued Pretrial Order No. 64, clarifying the Court’s ruling (Rec. Doc. 784) on Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Superior Courts of California (Rec. Doc. 469).

The Court issued Case Management Order No. 8, establishing the procedures and deadlines applicable to the second bellwether trial, which is set for Monday, January 28, 2019 at 8:30 a.m.

The Court issued Case Management Order No. 7, establishing the general discovery protocol for the 505(b)(2) Defendants.

The Court held a status conference with Plaintiffs Liaison Counsel, Dawn M. Barrios and M. Palmer Lambert, and Defendants’ Liaison Counsel, Douglas J. Moore and John F. Olinde.

The Court issued Pretrial Order No. 63, setting the next meeting of liaison counsel for Friday, October 6, 2017, at 9:30 a.m.

The Court issued Pretrial Order No. 62, ordering that the Master Answer deadline for each Defendant is Monday, October 16, 2017.

The Court issued Pretrial Order No. 61, dismissing Counts Two and Eight of Plaintiffs’ First Amended Master Long Form Complaint and granting individual plaintiffs fourteen (14) days to amend their Short Form Complaint to allege analogous state law claims that may be viable on an individual basis.

A status conference was held on this date with Magistrate Judge Michael B. North.

The Court issued Pretrial Order No. 60A, amending and superseding Pretrial Order No. 60 (Rec. Doc. 819) and ordering the collection of data of potential claimants by the Plaintiffs’ Settlement Committee.

A status conference was held in Judge Engelhardt’s courtroom at 10:00 a.m. Discussed were those items set forth in Joint Report No. 5 (Rec. Doc. 839).

The Court issued Pretrial Order No. 60, ordering the collection of data of potential claimants by the Plaintiffs’ Settlement Committee.

The Court issued Pretrial Order No. 59, ordering that the submission date on Defendants Sanofi-Aventis U.S. LLC and Sanofi US Services Inc.’s Motion to Dismiss Claims Barred by the Applicable Statutes of Limitations (Rec. Doc. 494) be continued until Wednesday, November 8, 2017.

The Court held oral argument on Defendants’ Motion to Dismiss Plaintiffs’ Master Long Form Complaint (Rec. Doc. 489), and the Court ruled on the motion as well as on Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Superior Courts of California (Rec. Doc. 469) and Delaware Plaintiffs’ Motion to Remand to the Superior Court of Delaware (Rec. Doc. 473).

Magistrate Judge Michael B. North ruled on outstanding disputes concerning Defendants' responses to jurisdictional interrogatories.

The Court issued Case Management Order No. 6, setting four bellwether trial dates in 2019.

The Court issued Case Management Order No. 5, setting forth the protocol for general discovery as to the Sanofi Defendants.

A status conference was held on this date with Magistrate Judge Michael B. North

The Court issued Pretrial Order No. 58, granting the request for oral argument in connection with Defendant’ Motion to Dismiss Plaintiffs’ Master Long Form Complaint (Rec. Doc. 489) and setting oral argument for Wednesday, August 30, 2017, at 9:30 a.m.

Magistrate Judge Michael B. North held a hearing on Plaintiffs’ Motion to Compel Responses to Requests for Production (Rec. Doc. 626).

The Court issued Pretrial Order No. 57, setting the next meeting of liaison counsel for Thursday, August 17, 2017, at 10:00 a.m.

The Court issued Pretrial Order No. 56, establishing the procedure for issuance of Summons while the Clerk’s Office corrects Defendants’ names within the CM/ECF system.

The Court issued Pretrial Order No. 39A, amending and superseding Pretrial Order No. 39 (Rec. Doc. 327) and establishing the protocol for streamlined service on Sun Pharmaceutical Industries, Inc.

The Court issued Pretrial Order No. 32A, amending and superseding Pretrial Order No. 32 (Rec. Doc. 307) and establishing the protocol for streamlined service on Actavis LLC f/k/a Actavis Inc. and Actavis Pharma, Inc.

A status conference was held on this date with Magistrate Judge Michael B. North.

Plaintiffs’ First Amended Master Long Form Complaint was entered into the record.

The Court issued Pretrial Order No. 55, attaching Plaintiffs’ First Amended Master Long Form Complaint to be entered into the record, ordering the revised Plaintiff Fact Sheet be substituted in place of the current version (Rec. Doc. 236-1), and ordering the revised Exemplar Short Form Complaint be substituted in place of the current version (Rec. Doc. 318-1).

The Court issued Pretrial Order No. 54, setting forth the requirements for voluntary dismissals without prejudice that would result in dismissal of an entire action against all named Defendants.

The Court issued Case Management Order No. 4, establishing the protocol to govern the initial phase of case-specific discovery for cases identified in Case Management Order No. 3 (Rec. Doc. 669).

The Court issued Case Management Order No. 3, establishing the procedures and deadlines applicable to the first bellwether trial as well as identifying the pool of plaintiffs for such trial, which is set for Monday, September 24, 2018 at 8:30 a.m.

The Court issued Pretrial Order No. 53, allowing Plaintiffs to amend their Master Long Form Complaint, Exemplar Short Form Complaint, and Plaintiff Fact Sheet in order to: (1) replace defendant Hospira Worldwide, Inc. with Hospira Worldwide, LLC f/k/a Hospira Worldwide, Inc.; (2) remove defendant Sun Pharma Global Inc.; (3) replace defendant Caraco Pharmaceutical Laboratories Ltd. with Sun Pharmaceutical Industries, Inc. f/k/a Caraco Pharmaceutical Laboratories Ltd.; and (4) replace Allergan Finance LLC f/k/a Actavis Inc. with Actavis LLC f/k/a Actavis Inc.

The Court issued Pretrial Order No. 52, setting deadlines related to personal jurisdiction and potential discovery protocols, as discussed during the teleconference that took place on Wednesday, July 12, 2017 at 10:00 a.m.

The Court issued Pretrial Order No. 51, setting various deadlines discussed during the July 7, 2017 status conference and scheduling the next status conference for Friday, September 8, 2017 at 10:00 a.m. in Judge Engelhardt’s courtroom, with the meeting of liaison counsel at 8:30 a.m. and meeting of the Plaintiffs’ Steering Committee at 9:00 a.m. The Court has set up a conference line for the status conference. To participate, call (800) 260-0712 and enter access code 427302. 

The Court issued an Order and Reasons, denying Plaintiffs’ Motion to Certify Class (Reference: 16-17731) for essentially the reasons stated in Defendant sanofi-aventis U.S. LLC’s memorandum in opposition.

The Court conducted a teleconference with counsel to discuss issues related to discovery and personal jurisdiction.

A status conference was held in Judge Engelhardt’s courtroom at 10:00 a.m. Discussed were those items set forth in Joint Report No. 4 (Rec. Doc. 622).

The Court held oral argument on “Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Superior Courts of California” (Rec. Doc. 469) and “Delaware Plaintiffs’ Motion to Remand to the Superior Court of Delaware” (Rec. Doc. 473). No oral argument was held on “Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Twenty-Second Judicial Circuit, City of St. Louis, State of Missouri” (Rec. Doc. 467), as the parties are to file a written submission regarding this motion at a later date.

The Court issued Pretrial Order No. 50, granting Plaintiffs’ Liaison Counsel’s and Defendants’ Liaison Counsel’s Consent Motion to adopt the Protective Order and adopting the Protective Order as Pretrial Order No. 50.

The Court issued Pretrial Order No. 49, granting Plaintiffs’ Liaison Counsel’s and Defendants’ Liaison Counsel’s Consent Motion to adopt the Electronically Stored Information Protocol and adopting the Electronically Stored Information Protocol Order as Pretrial Order No. 49.

The Court issued Pretrial Order No. 26A, modifying Pretrial Order No. 26 (Rec. Doc. 289) to permit Julie A. Callsen to be substituted in place and stead of Chad A. Sullivan to serve as the defense counsel to attend such meetings on behalf of Accord Healthcare, Inc.

The Court issued an Order, granting Plaintiffs’ Consent Motion to Re-set Submission Date of Defendant Sanofi-Aventis U.S. LLC’s Motion for Disclosure of Non-Party Interested Entities or Persons (Rec. Doc. 559) and resetting the submission date for Wednesday, August 2, 2017.

The Court held a status conference with Plaintiffs Liaison Counsel, Dawn M. Barrios and M. Palmer Lambert, and Defendants’ Liaison Counsel, Douglas J. Moore and John F. Olinde.

The Court issued an Order, scheduling status conferences with Magistrate Judge Michael B. North for Wednesday, July 26, 2017 at 2:00 p.m. and Friday, August 18, 2017 at 10:00 a.m.

The Court issued Pretrial Order No. 48, resetting oral argument on “Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Twenty-Second Judicial Circuit, City of St. Louis, State of Missouri” (Rec. Doc. 467), “Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Superior Courts of California” (Rec. Doc. 469), and “Delaware Plaintiffs’ Motion to Remand to the Superior Court of Delaware” (Rec. Doc. 473) for Thursday, July 6, 2017, at 10:30 a.m.

The Court issued Pretrial Order No. 47, setting oral argument on “Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Twenty-Second Judicial Circuit, City of St. Louis, State of Missouri” (Rec. Doc. 467), “Plaintiffs’ Omnibus Motion to Remand Certain Cases to the Superior Courts of California” (Rec. Doc. 469), and “Delaware Plaintiffs’ Motion to Remand to the Superior Court of Delaware” (Rec. Doc. 473) for Wednesday, June 21, 2017 at 10:00 a.m.

The Court issued Pretrial Order No. 40A, amending and superseding Pretrial Order No. 40 (Rec. Doc. 328) and establishing the protocol for streamlined service of process on Hospira, Inc., Hospira Worldwide, LLC f/k/a Hospira Worldwide, Inc., and Pfizer Inc.

The Court issued Case Management Order No. 2, setting deadlines for foreign merits discovery relevant to the French Sanofi entities.

The Court issued Case Management Order No. 1, setting deadlines for personal jurisdiction discovery relevant to Sanofi’s and Aventis Pharma S.A.’s Motion to Dismiss (Rec. Doc. 346).

A status conference specifically relating to Electronically Stored Information (ESI) was held with Magistrate Judge Michael B. North. Discussed were those items set forth within the Minute Entry, and a telephone status conference with Magistrate North was tentatively scheduled for Tuesday, May 30, 2017 at 10:00 a.m.

The Court issued Pretrial Order No. 46, scheduling the next meeting with liaison counsel for Friday, June 23, 2017 at 9:00 a.m., setting the deadline for the submission of a proposed order regarding a discovery schedule and bellwether trial dates as Friday, May 26, 2017, and setting the deadline for the submission of a proposed schedule for discovery specifically related to the issue of personal jurisdiction as Wednesday, May 17, 2017.

The Court issued Pretrial Order No. 45, setting the briefing schedule for omnibus motions to remand that applies only to cases transferred to this Court via Conditional Transfer Order in which a decision has not yet been rendered on remand, regardless of whether a motion to remand was previously filed in the transferor court.

A status conference was held in Judge Engelhardt’s courtroom at 10:00 a.m. Discussed were those items set forth in Joint Report No. 3 (Rec. Doc. 454).

The Court issued Pretrial Order No. 44, appointing counsel to the 505(b)(2) Defendants’ Settlement Committee

The Court issued an Order, granting Defendants’ Motion to Reset Submission Date on Plaintiffs’ Motion to Certify Class (Reference: 16-17731) and resetting the submission date to June 21, 2017.

The Court issued Pretrial Order No. 43, setting the deadline for nominations of counsel to be appointed to the Settlement Committee on behalf of the 505(b)(2) Defendants as Friday, April 28, 2017, setting the parameters of the Science Day presentations taking place on May 3, 2017, setting the submission date for the Motions to Remand discussed at the meeting with liaison counsel as Wednesday, June 21, 2017, and setting the date of the next general status conference as Friday, July 7, 2017, at 10:00 a.m. in Judge Engelhardt’s courtroom, with the meeting of liaison counsel at 8:30 a.m. and the meeting of the Plaintiffs’ Steering Committee at 9:00 a.m. The Court has set up a conference line for the status conference. To participate, call (800) 260-0712 and enter access code 423344.

The Court issued Pretrial Order No. 42, ordering that a plaintiff’s filing of a Short Form Complaint does not trigger any responsive pleading deadline on the part of any Defendant at this time.

The Court issued Pretrial Order No. 41, granting Plaintiffs’ Liaison Counsel’s Motion to Amend Exhibit A to Pretrial Order No. 37 and amending Exhibit A to Pretrial Order No. 37 (Rec. Doc. 318-1).

The Court issued Pretrial Order No. 40, establishing the protocol for streamlined service of process on Hospira Worldwide, LLC, formerly doing business as Hospira Worldwide, Inc., and Pfizer Inc.

The Court issued Pretrial Order No. 39, establishing the protocol for streamlined service of process on Sun Pharma Global Inc.

The Court issued Pretrial Order No. 38, ordering that the Plaintiff Fact Sheet (Exhibit “A” to Pretrial Order No. 18, Rec. Doc. 236-1) and the Defendant Fact Sheet (Exhibit “B” to Pretrial Order No. 18, Rec. Doc. 236-2) be and are hereby updated and replaced with the corrected version of these documents.

The Court issued Amended Pretrial Order No. 22, which supersedes and amends Pretrial Order No. 22 (Rec. Doc. 279) and governs the form and schedule for service of Plaintiff Fact Sheets and Defendant Fact Sheets.

The Court issued Pretrial Order No. 37, attaching the exemplar Short Form Complaint to be used by counsel when filing their complaints as provided by this Order and Pretrial Order No. 15 (Rec. Doc. 230). The PDF version of the exemplar Short Form Complaint is available under the “Forms” tab on this webpage.

The Court issued Pretrial Order No. 36, withdrawing the deadline to submit proposed orders regarding streamlined service of process as to Defendants Eagle Pharmaceuticals, Inc. and NorthStar Rx LLC

The Court issued Pretrial order No. 35, scheduling a meeting between the Settlement Committees and the Court on Wednesday May 3, 2017, following the conclusion of the “Science Day” presentations scheduled for this date. Furthermore, the Court will hold a follow-up meeting with the Settlement Committees on Friday, May 12, 2017, following the conclusion of the general status conference scheduled for this date.

Plaintiffs’ Liaison Counsel filed the Master Long Form Complaint.

The Court issued Pretrial Order No. 34, extending the deadline to submit proposed orders establishing a protocol for streamlined service of process as to Eagle Pharmaceuticals, Inc. and NorthStar RX LLC to Monday, April 3, 2017.

The Court issued Pretrial Order No. 33, establishing the protocol for the streamlined service of process on McKesson Corporation.

The Court issued Pretrial Order No. 32, establishing the protocol for streamlined service of process for Actavis Pharma, Inc.

The Court issued Pretrial Order No. 31, granting Plaintiffs’ Liaison Counsel’s Motion to Amend Exhibit B (Rec. Doc. 262-2) to Pretrial Order No. 19 (Rec. Doc. 262) regarding task codes for common benefit work and ordering that Exhibit B to Pretrial Order No. 19 be and is hereby updated to include the amended list of Litigation Task Codes/Categories. 

The Court issued Pretrial Order No. 30, establishing the protocol for streamlined service of process for Sandoz Inc. 

The Court issued Pretrial Order No. 29, establishing the protocol for streamlined service of process for Accord Healthcare, Inc. 

The Court issued Pretrial Order No. 28, scheduling the next meeting of liaison counsel and the Court for Friday, April 21, 2017, at 9:00 a.m. in Judge Engelhardt’s chambers. 

The Court issued Pretrial Order No. 27, setting various deadlines, scheduling “Science Day” with the Court for Wednesday, May 3, 2017, at 8:30 a.m., and scheduling the next status conference with the Court for Friday, May 12, 2017, at 10:00 a.m. in Judge Engelhardt’s courtroom, with the meeting of liaison counsel at 8:30 a.m. and meeting of the Plaintiffs’ Steering Committee at 9:00 a.m. The Court has set up a conference line for the status conference. To participate, call (800) 260-0712 and enter access code 421090. 

A status conference was held in Judge Engelhardt’s courtroom at 10:00 a.m. Discussed were those items set forth in Joint Report No. 2 (Rec. Doc. 290). 

The Court issued Pretrial Order No. 26, designating defense counsel to attend the Plaintiffs’ Steering Committee Meetings that take place prior to each general status conference. 

A status conference specifically relating to Electronically Stored Information (ESI) was held with Magistrate Judge Michael B. North. Discussed were those items set forth within the Minute Entry, and a Discovery Status Conference with Magistrate North was tentatively scheduled for Tuesday, May 16, 2017 at 9:00 a.m. 

The Court issued Pretrial Order No. 25, accepting the nomination of John F. Olinde to serve as Defense Liaison Counsel on behalf of the 505(b)(2) Defendants. 

The Court issued Pretrial Order No. 24, ordering submission and service of Plaintiff and Defendant Fact Sheets through the online MDL Centrality System and amending the procedure set forth in Pretrial Order No. 1 for transmittal of Orders and Notices by Plaintiffs’ Liaison Counsel.

The Court issued Pretrial Order No. 23, ordering that the Plaintiff Fact Sheet (Exhibit “A” to Pretrial Order No. 18, Rec. Doc 236-1) be and is hereby updated to include the approved authorizations, as ordered by Pretrial No. 18 (Rec. Doc. 236).